These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 12550109)
41. [Total magnesium in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis]. Iłzecka J; Stelmasiak Z; Kot A Neurol Neurochir Pol; 2000; 34(4):699-706. PubMed ID: 11105302 [TBL] [Abstract][Full Text] [Related]
42. Biomarker-based predictive models for prognosis in amyotrophic lateral sclerosis. Su XW; Simmons Z; Mitchell RM; Kong L; Stephens HE; Connor JR JAMA Neurol; 2013 Dec; 70(12):1505-11. PubMed ID: 24145899 [TBL] [Abstract][Full Text] [Related]
43. Serum level of transforming growth factor-beta1 (TGF-beta1) and the expression of TGF-beta receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis. Sakaguchi K; Kitano M; Nishimura M; Senoh T; Ohta T; Terao M; Shinji N; Koide N; Tsuji T Hepatogastroenterology; 2004; 51(60):1780-3. PubMed ID: 15532825 [TBL] [Abstract][Full Text] [Related]
44. Evaluating the levels of CSF and serum factors in ALS. Guo J; Yang X; Gao L; Zang D Brain Behav; 2017 Mar; 7(3):e00637. PubMed ID: 28293476 [TBL] [Abstract][Full Text] [Related]
52. Total antioxidant status is increased in the serum of amyotrophic lateral sclerosis patients. Iłzecka J Scand J Clin Lab Invest; 2003; 63(4):297-302. PubMed ID: 12940638 [TBL] [Abstract][Full Text] [Related]
53. Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Jiménez-Jiménez FJ; Hernánz A; Medina-Acebrón S; de Bustos F; Zurdo JM; Alonso H; Puertas I; Barcenilla B; Sayed Y; Cabrera-Valdivia F Acta Neurol Scand; 2005 Feb; 111(2):114-7. PubMed ID: 15644071 [TBL] [Abstract][Full Text] [Related]
54. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Mitchell RM; Freeman WM; Randazzo WT; Stephens HE; Beard JL; Simmons Z; Connor JR Neurology; 2009 Jan; 72(1):14-9. PubMed ID: 18987350 [TBL] [Abstract][Full Text] [Related]
55. Transforming growth factor-beta 2 causes an acute improvement in the motor performance of transgenic ALS mice. Day WA; Koishi K; Nukuda H; McLennan IS Neurobiol Dis; 2005; 19(1-2):323-30. PubMed ID: 15837588 [TBL] [Abstract][Full Text] [Related]
56. Interleukin-17 and interleukin-23 are elevated in serum and cerebrospinal fluid of patients with ALS: a reflection of Th17 cells activation? Rentzos M; Rombos A; Nikolaou C; Zoga M; Zouvelou V; Dimitrakopoulos A; Alexakis T; Tsoutsou A; Samakovli A; Michalopoulou M; Evdokimidis J Acta Neurol Scand; 2010 Dec; 122(6):425-9. PubMed ID: 20219021 [TBL] [Abstract][Full Text] [Related]
57. Auto-antibodies against proteins of spinal cord cells in cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS). Niebroj-Dobosz I; Dziewulska D; Janik P Folia Neuropathol; 2006; 44(3):191-6. PubMed ID: 17039414 [TBL] [Abstract][Full Text] [Related]
58. EMMPRIN levels in serum of patients with amyotrophic lateral sclerosis. Iłżecka J Acta Neurol Scand; 2011 Dec; 124(6):424-8. PubMed ID: 21554254 [TBL] [Abstract][Full Text] [Related]
59. Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum. Süssmuth SD; Tumani H; Ecker D; Ludolph AC Neurosci Lett; 2003 Dec; 353(1):57-60. PubMed ID: 14642437 [TBL] [Abstract][Full Text] [Related]
60. Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis. Tanaka M; Kikuchi H; Ishizu T; Minohara M; Osoegawa M; Motomura K; Tateishi T; Ohyagi Y; Kira J J Neuropathol Exp Neurol; 2006 Aug; 65(8):816-25. PubMed ID: 16896315 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]